Dr Jean-Pierre
Scheerlinck, MSc,
DiplEd, PhD, MBA, FAICD

Director

Centre for Animal Biotechnology
The University of Melbourne
Vic 3010, Australia
Telephone: + 61 3 8344 4441
Mobile: 0402 584 108
E-mail: j.scheerlinck@unimelb.edu.au

Links

CAB home
CAB Cellular Immunology
Allergenix Pty Ltd

Positions held

2015-2019: Director, Centre for Animal Biotechnology, The University of Melbourne (Australia). Porefssor & Associate Dean/Director (Graduate Research)
2011-2015: Director, Centre for Animal Biotechnology, The University of Melbourne (Australia). Associate Dean/Director (International)
2009-2011: Director, Centre for Animal Biotechnology, The University of Melbourne (Australia). Deputy Head of Department (Faculty of Veterinary Science, Parkville)
2003–2009: Director, Centre for Animal Biotechnology, The University of Melbourne (Australia).
2000–2005: Business Manager and Senior Research Fellow, Centre for Animal Biotechnology, The University of Melbourne (Australia).
1996–2000: Project Leader, CSIRO (Australia).
1994–1996: Post-Doctoral Fellow, The Walter and Eliza Hall Institute (Australia).
1992–1994: Post-Doctoral Fellow, International Livestock Research Institute (Kenya).

Jean-Pierre is the author of over 80 articles in refereed journal and is a Co-Editor-in Chief of " Veterinary Immunology and Immunopathology". Jean-Pierre is also a Fellow of the Australian Institute of Company Directors.

Tertiary education

2002: MBA(Technol Mgt), Deakin Univ., Australia (Distinction).
1992: Doctor of Sciences. VUB, Belgium. (Cum laude) Thesis: "Scrutiny of subunit immunogens".
1991: Master in Biol and Biotechnol. VUB, Belgium. (Highest distinction)
1987: Diploma of Education. VUB, Belgium. (High distinction)
1987: Master in Zoological Science. VUB, Belgium. (Highest distinction)

Research interests

• Regulation of immune responses and lymphocyte recirculation
• Development of protein and DNA vaccines
• Animal models for human diseases
• Infectious diseases

Supervised students

• M Shahnia (PhD, Started June 2017) Investigating wound healing using a pig model
• R Owen (PhD, Started March 2016) Impact of Varroa destructir on the honeybees in Australia
• F Baloch ((PhD, Started Nov 2015) Investigation of graft rejection in corneal transplatation using a sheep model
• M G Tedla (PhD, Started Aug 2015) Immunomodulation by Schistosoma mansoni
• S N V Dewage ( PhD started May 2015) Investigation of lung fibriosis usin a sheep model
• C Madona D'Souza (PhD 2017) Role of non-classical T cells during infection
• T Anupama Mahakapuge (PhD, 2017) Investigation of modulation of immune responses to pathogens
• M Nahar (PhD, 2017) Investigation of immune memory resilience
• F Ahmed (MAgSc, 2015) Generation of a novel construct for the expression of ovalbumin in Schistosoma mansoni
• A Timothy (MPhil, 2014) Inducting immune responses via intra-pulmonary vaccination
• S Mangiola (MPhil, 2013) Investigation of neglected parasitic diseases using a bioinformatics approach
• A Vujanic (PhD, 2012) Mechanism of induction of the immune response following lung vaccination
• J Van der Velden (PhD, 2011) Study of chronic asthma in sheep
• J Ravichandran (Hon, 2007) Activation of sheep dendritic cells by CpG motives in vivo
• H-H. Yen (PhD, 2006) Modulation of Immune Response to DNA vaccines in sheep.
• R. De Rose (PhD, 2004) Immune response following DNA vaccination.
• J. Uilenreef (MSc, 2000) Cytokine responses in Johne's Disease.
• M. Riffkin (PhD, 1997) Immunoregulation by Trichostrongylus colubriformis.
• T. Van de Putte (MSc, 1993) Immunity to Theileira parva in young cattle.
• P. Stass (MSc, 1991) Computer modelling of the peptide MHC interactions.
• A. Geldhoff (MSc, 1990) Antigen presentation.

Selected papers

• Saxena V. K., A Diaz and J-P. Y. Scheerlinck (2019). Identificavtion and characterization of an M cell marker in nasopharynx- and oropharynx-associated lymph tissue in sheep. Vet Immunol Immunoathol 208, 1-5
• D'Souza C., T Pediongco, H. Wang, J-P. Y. Scheerlinck, L. Kostenko, R Esterbauer, A. W. Stent, S. B. G. Eckle, D. S. Meehan, R. A. Strugnell, H. Cao, L. Liu, J. Y. W. Mak, G Lovrecs, L. Lu, D. P. Fairlie, J. Rossjohn, J. Mccluskey, A. L. Every, Z. Chen, A. J. Corbert (2018) Mucosal-associated invariant T cells augment immunopthology and gastritis in chronic Helicobacter pylori infection. J. Immunol. 200:5, 1901-1916
• Hagen J., J-P. Y. Scheerlinck and R. B. Gasser (2015). Knocking down schistosomes - promise for virus-based transduction in parasites. Trend Parasitol 31:7, 324-332
• Scheerlinck J-P. Y, K. J. Snibson, V. M. Bowles, P. Sutton (2008). Biomedical applications of sheep models: From asthma to vaccines. Trends Biotechnol 26, 259-266.
• Yen H-H. and J-P. Y. Scheerlinck (2007). Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation. Vaccine 25:14, 2575-82
• Scheerlinck J.-P. Y. (2001). Genetic adjuvants for DNA vaccines. Vaccine 19:17-19, 2647-2656.
• Gerondakis S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-P. Y. Scheerlinck and R. J. Grumont. (1996). Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 93, 3405–3409.
• Lucas R., S. Magez, R. Deleys, L. Fransen, J.-P. Scheerlinck, M. Rampelberg, E. Sablon and P. De Baetselier. (1994). Mapping the lectin like activity of tumor necrosis factor. Science. 263, 814–817.